MusclePharm has announced expected unaudited gross revenues for the fourth quarter ended 31December 2011 of approximately $8,000,000, a 830% increase, as compared to $860,000 for the same quarter ended 31December 2010.
Subscribe to our email newsletter
The company sales for the twelve months of 2011 are approximately $21,000,000, which is an increase of 425%, compared to all of 2010 sales of $4,000,000, the company said.
The nutritional supplement company expects to report a net operating loss and a loss associated with convertible financing derivatives for the three months ended 31December 2011.
MusclePharm CEO Brad Pyatt said their expanding product line and distribution combined with their brand recognition positions them for accelerated growth over the coming months.
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.